Acetyl L-carnitine does not improve age-related hearing loss in rats
Author Information
Author(s): Bielefeld Eric C, Coling Donald, Chen Guang-Di, Henderson Donald
Primary Institution: Center for Hearing and Deafness, State University of New York at Buffalo
Hypothesis
Can long-term ALCAR treatment prevent or reverse age-related hearing loss in Fischer 344/NHsd rats?
Conclusion
The study found no evidence that ALCAR treatment alters age-related hearing loss in Fischer 344/NHsd rats.
Supporting Evidence
- ALCAR was administered to rats at different ages to evaluate its effects on hearing loss.
- Hearing thresholds were measured using auditory brainstem responses before, during, and after treatment.
- No significant differences were found between treated rats and controls at any frequency tested.
Takeaway
The researchers gave a medicine called ALCAR to rats to see if it would help their hearing as they got older, but it didn't work.
Methodology
The study used three different dosing strategies of ALCAR in aging rats and measured their hearing using auditory brainstem responses.
Limitations
The study did not test higher doses of ALCAR or start treatment at an earlier age, which may have affected the results.
Participant Demographics
Fischer 344/NHsd male albino rats aged 15 to 24 months.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website